Patents by Inventor Lars, Georg ENGSTRAND

Lars, Georg ENGSTRAND has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Autologous fecal sample for use in the treatment of microbial dysbiosis
    Patent number: 11045501
    Abstract: The present disclosure relates to the use of autologous fecal samples obtained from a subject for use in prevention and/or treatment of microbial dysbiosis in the gastrointestinal tract in said subject and to related pharmaceutical compositions for oral administration. The disclosed autologous fecal samples are useful for treatment of microbial dysbiosis in the gastrointestinal tract associated with medical treatment and/or various indications, including chronic disease and infectious disease, for example Clostridium difficile infection.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: June 29, 2021
    Assignee: BACTAVIVA AB
    Inventors: Hans Peter Torsten Ekre, Lars Georg Engstrand, Ola Gosta Flink, Otto Sten Gunnar Skolling
  • AUTOLOGOUS FECAL SAMPLE FOR USE IN THE TREATMENT OF MICROBIAL DYSBIOSIS
    Publication number: 20200046777
    Abstract: The present disclosure relates to the use of autologous fecal samples obtained from a subject for use in prevention and/or treatment of microbial dysbiosis in the gastrointestinal tract in said subject and to related pharmaceutical compositions for oral administration. The disclosed autologous fecal samples are useful for treatment of microbial dysbiosis in the gastrointestinal tract associated with medical treatment and/or various indications, including chronic disease and infectious disease, for example Clostridium difficile infection.
    Type: Application
    Filed: January 19, 2018
    Publication date: February 13, 2020
    Inventors: Hans, Peter, Torsten EKRE, Lars, Georg ENGSTRAND, Ola, Gosta FLINK, Otto, Sten, Gunnar SKOLLING